DOI: https://doi.org/10.26641/2307-0404.2018.3(part1).142364

The phenotypes of chronic heart failure in patients with ischemic heart disease combined with chronic obstructive pulmonary disease.

V. A. Potabashniy

Abstract


The aim of this study: on the basis of clinical and instrumental complex investigation of 320 patients with chronic heart failure (CHF) of ischemic etiology combined with chronic obstructive pulmonary disease (COPD) it was proposed to identify several phenotypes of including CHF with preserved ejection fraction (CHFpEF) without right ventricular dysfunction (RVD); CHFpEF with RVD; CHFpEF with right-side failure (RSF); CHF with reduced EF (CHFrEF) plus RSF (biventricular). Identification of these phenotypes creates the pathophysiologic basis to development of rathional pharmacotherapy of CHF in patients with ischemic heart disease combined with COPD.


Keywords


heart failure; phenotypes; ischaemic heart disease; chronic obstuctive pulmonary disease

References


[Recomendation of the Association of Cardiology of Ukraine diagnostic and treatment Chronic Heart Fai­lure (2017)]. Serceva nedostatnist ta komorbidny stany 2017;1:64.

[Order of the Ministry of Health of Ukraine dated June 27, 2013 N 555 "On Approval anv Implementation of Medical-Technological Documents for the Standar­dization of Medical Assistance in Chronic Obstructive Pulmonary Disease]. Kyiv; 2013. Ukrainian.

[Order of the Ministry of Health of Ukraine dated March 2, 2016 N 152 "On Approval anv Implementation of Medical-Technological Documents for the Standar­dization of Medical Assistance in Stable Ischemic Heart Disease]. Kyiv; 2016. Ukrainian.

Lourenco AP, Leite-Moreira AF, Balligand J-L et al. An integrative translational approach to study heart fai­lure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the Euro­pean Society of Cardiology. Eur.J. Heart Fail. 2018;20:216-227.

Hohendanner F, Messroghli D, Bode D et al. Atrial remodelling in heart failure: recent development and relevance for heart failure with preserved ejection fraction. ESC Heart Failure. 2018;5:211-21.

Canepa M, Struburzynska-Migaj E, Drozdz J et al.Characteristics, treatment and 1-year prognosis of hos­pitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry. Eur. J. Heart Fail. 2018;20:100-10.

Wolsk E, Claggett B.,Kober L et al. Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure. Eur. J. Heart Fail. 2018;20:,504-10.

Gopal D, Wang J, Han Y. Determinants of normal left atrial volume in heart failure with moderate-to-severely reduced ejection fraction. Cardiology Research and Practice 2018;8. doi: doi.org/10.1155/2018/7512758

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Europ. J. Heart Fail. 2016;85. doi: 10.1002/ejhf.592

Konstam MA, Kiernan MS, Bernstein D et al. Eva­luation and Management of Right-Sided Heart Failure. A Scientific Statement From the American Heart Association. Circulation 2018.137.47. doi: 10.1161/CIR.0000000000000560

Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, ma­nagement and prevention of chronic obstructive pulmo­nary disease (Updated 2017). Medical Communications Resources; 2017.

Luscher TF. Heart failure subgroup: HFrEF, HFmrEF, and HFpEF with or without mitral regur­gitation. Eur. Heart J. 2018;39:1-4.

Luscher TF. Mechanisms and outcomes of heart failure: from HFpEF, HFmrEF, and HFrEF to trans­plantation. Eur. Heart J. 2018;39:1749-53.

Practice guidelines for the management of arterial hypertension of the European Society of Hy­per­tension (ESH) and the European Society of Cardiology(ESC). J. Hyper­tens. 2013;31:1925-38 doi: 10.1097/HJH.0b013e328364ca4c

Recommendations for cardiac chamber quantifi­cation by echocardiography: an update from the American Society of Echocardiography and the European Asso­ciation of Cardiovascular Imaging. J. Am. Soc. Echo­cardiogr. 2015;28:1-39.

Gorter TM, van Veldhuisen D, Bauersachs J et al. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and mana­gement. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 2018;20:16-37.

Galderisi M, Cosyns B., Edvardsen T, Cardim Nuno et al. Standardization of adult transthoracic echo­cardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging. Eur. Heart J. - Cardiovasc. Imaging. 2017;18:1301-10.


GOST Style Citations


  1. Рекомендації Асоціації кардіологів України з діагностики та лікування хронічної серцевої не­достатності (2017) // Серцева недостатність та комор­бідні стани. - 2017. - Додаток № 1. - 64 с.
  2. Уніфікований клінічний протокол первинної, вторинної (спеціалізованої), третинної (високоспе­ціалізованої) медичної допомоги та медичної реабі­літації «Хронічне обструктивне захворювання ле­гень»: Наказ МОЗ України від 27.06.2013 № 555. – Київ, МОЗ України, 2013. – 92 с.
  3. Уніфікований клінічний протокол первинної, вторинної (спеціалізованої), третинної (високоспе­ціалі­зованої) медичної допомоги «Стабільна ішемічна хво­роба серця»: Наказ МОЗ України № 152 від 02.03.2016.
  4. An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology / A.P. Lourenco, A.F. Leite-Moreira, J.-L. Balligand [et al.] // Eur.J. Heart Fail. - 2018. - Vol.20. - P.216-227.
  5. Atrial remodelling in heart failure: recent de­velopment and relevance for heart failure with preserved ejection fraction / F.Hohendanner, D.Messroghli, D.Bode [et al.] // ESC Heart Failure. - 2018.- Vol.5. - P. 211-221.
  6. Characteristics, treatment and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry / M.Canepa, E.Struburzynska-Migaj, J.Drozdz [et al.] // Eur. J. Heart Fail. - 2018. - Vol.20. - P. 100-110.
  7. Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure / E. Wolsk, B.Claggett, L. Kober [et al.] // Eur. J. Heart Fail. - 2018. - Vol. 20. - P. 504-510.
  8. Determinants of normal left atrial volume in heart failure with moderate-to-severely reduced ejection frac­tion / D. Gopal, J. Wang, Y. Han // Cardiology Re­search and Practice. – Vol. 2018. - 8 p. doi.org/10.1155/2018/7512758
  9. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure // Eur. J. Heart Fail. - 2016. - 85p. doi:10.1002/ejhf.592
  10. Evaluation and Management of Right-Sided Heart Failure. A Scientific Statement From the American Heart Association / M.A. Konstam, M.S. Kiernan, D. Bernstein [et al.] // Circulation. - 2018.- Vol. 137. – 47 p. doi: 10.1161/CIR.0000000000000560
  11. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pul­monary disease (Updated 2017) // Medical Commu­nica­tions Resources.–2017.
  12. Luscher T.F. Heart failure subgroup: HFrEF, HFmrEF, and HFpEF with or without mitral regurgitation / T.F.Luscher // Eur. Heart J. – 2018. – Vol. 39. – P. 1-4.
  13. Luscher T.F. Mechanisms and outcomes of heart failure: from HFpEF, HFmrEF, and HFrEF to transplan­tation / T.F.Luscher // Eur. Heart J. – 2018. – Vol. 39. – P. 1749-1753.
  14. Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) // J. Hypertens. – 2013. – Vol. 31. – P. 1925-1938 doi: 10.1097/HJH.0b013e328364ca4c
  15. Recommendations for cardiac chamber quanti­fication by echocardiography: an update from the Ame­rican Society of Echocardiography and the European Association of Cardiovascular Imaging // J.Am.Soc. Echo­cardiogr. – 2015. – Vol. 28. – P. 1-39.
  16. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and mana­gement. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology / T.M. Gorter, D. van Veldhuisen, J.Bauersachs [et al.] // Eur.J.Heart Fail. – 2018. – Vol. 20. – P. 16-37.
  17. Standardization of adult transthoracic echocardio­graphy reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging / M. Galderisi, B. Cosyns, T. Edvardsen, Nuno Cardim [et al.] // Eur. Heart J. Cardiovasc. Imaging. – 2017. – Vol. 18. – P. 1301-1310.